SIMCERE PHARMAC Stock Forward View - Simple Regression
| S2P Stock | EUR 1.31 0.01 0.77% |
SIMCERE Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of SIMCERE PHARMAC's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 20th of February 2026, the relative strength index (RSI) of SIMCERE PHARMAC's share price is approaching 48. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling SIMCERE PHARMAC, making its price go up or down. Momentum 48
Impartial
Oversold | Overbought |
Quarterly Earnings Growth 0.381 | Quarterly Revenue Growth 0.151 |
Using SIMCERE PHARMAC hype-based prediction, you can estimate the value of SIMCERE PHARMAC GRP from the perspective of SIMCERE PHARMAC response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of SIMCERE PHARMAC GRP on the next trading day is expected to be 1.22 with a mean absolute deviation of 0.05 and the sum of the absolute errors of 3.28. SIMCERE PHARMAC after-hype prediction price | EUR 1.31 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
SIMCERE |
SIMCERE PHARMAC Additional Predictive Modules
Most predictive techniques to examine SIMCERE price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for SIMCERE using various technical indicators. When you analyze SIMCERE charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
SIMCERE PHARMAC Simple Regression Price Forecast For the 21st of February
Given 90 days horizon, the Simple Regression forecasted value of SIMCERE PHARMAC GRP on the next trading day is expected to be 1.22 with a mean absolute deviation of 0.05, mean absolute percentage error of 0, and the sum of the absolute errors of 3.28.Please note that although there have been many attempts to predict SIMCERE Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that SIMCERE PHARMAC's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
SIMCERE PHARMAC Stock Forecast Pattern
| Backtest SIMCERE PHARMAC | SIMCERE PHARMAC Price Prediction | Research Analysis |
SIMCERE PHARMAC Forecasted Value
In the context of forecasting SIMCERE PHARMAC's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. SIMCERE PHARMAC's downside and upside margins for the forecasting period are 0.01 and 3.88, respectively. We have considered SIMCERE PHARMAC's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of SIMCERE PHARMAC stock data series using in forecasting. Note that when a statistical model is used to represent SIMCERE PHARMAC stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 112.5202 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0538 |
| MAPE | Mean absolute percentage error | 0.0408 |
| SAE | Sum of the absolute errors | 3.2796 |
Predictive Modules for SIMCERE PHARMAC
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as SIMCERE PHARMAC GRP. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.SIMCERE PHARMAC After-Hype Price Density Analysis
As far as predicting the price of SIMCERE PHARMAC at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in SIMCERE PHARMAC or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of SIMCERE PHARMAC, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
SIMCERE PHARMAC Estimiated After-Hype Price Volatility
In the context of predicting SIMCERE PHARMAC's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on SIMCERE PHARMAC's historical news coverage. SIMCERE PHARMAC's after-hype downside and upside margins for the prediction period are 0.07 and 3.96, respectively. We have considered SIMCERE PHARMAC's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
SIMCERE PHARMAC is dangerous at this time. Analysis and calculation of next after-hype price of SIMCERE PHARMAC GRP is based on 3 months time horizon.
SIMCERE PHARMAC Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as SIMCERE PHARMAC is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading SIMCERE PHARMAC backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with SIMCERE PHARMAC, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.16 | 2.65 | 0.00 | 0.00 | 5 Events / Month | 0 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.31 | 1.31 | 0.00 |
|
SIMCERE PHARMAC Hype Timeline
SIMCERE PHARMAC GRP is at this time traded for 1.31on Frankfurt Exchange of Germany. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. SIMCERE is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at -0.16%. %. The volatility of related hype on SIMCERE PHARMAC is about 9.223372036854776E16%, with the expected price after the next announcement by competition of 1.31. About 69.0% of the company outstanding shares are owned by corporate insiders. The book value of SIMCERE PHARMAC was at this time reported as 0.36. The company last dividend was issued on the 18th of June 2025. Assuming the 90 days horizon the next estimated press release will be in about 5 days. Check out Historical Fundamental Analysis of SIMCERE PHARMAC to cross-verify your projections.SIMCERE PHARMAC Related Hype Analysis
Having access to credible news sources related to SIMCERE PHARMAC's direct competition is more important than ever and may enhance your ability to predict SIMCERE PHARMAC's future price movements. Getting to know how SIMCERE PHARMAC's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how SIMCERE PHARMAC may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PQ9 | PT Bank Mandiri | 0.04 | 1 per month | 5.73 | 0.05 | 17.39 | (14.29) | 40.26 | |
| PQ9 | BANK MANDIRI | 0.00 | 3 per month | 2.87 | 0.07 | 5.00 | (4.76) | 26.79 | |
| PQ9 | BANK MANDIRI | 0.00 | 1 per month | 0.00 | 0.01 | 4.55 | 0.00 | 9.11 | |
| PQ9 | BANK MANDIRI | 0.00 | 0 per month | 0.00 | 0.01 | 4.00 | 0.00 | 24.58 | |
| BYRA | BANK RAKYAT IND | (0.04) | 1 per month | 0.00 | (0.09) | 0.00 | (5.00) | 35.71 | |
| BYRA | PT Bank Rakyat | 0.00 | 1 per month | 2.01 | 0.05 | 5.88 | (5.26) | 17.03 | |
| BYRA | PT Bank Rakyat | 0.00 | 0 per month | 4.07 | 0.03 | 11.11 | (10.00) | 26.67 | |
| BYRA | BANK RAKYAT IND | 0.00 | 0 per month | 0.00 | (0.02) | 5.88 | (5.56) | 12.13 | |
| BZG2 | BANK CENTRAL ASIA | 0.00 | 1 per month | 0.00 | (0.07) | 2.56 | (2.50) | 5.26 | |
| BZG2 | PT Bank Central | 0.00 | 1 per month | 0.00 | (0.03) | 7.50 | (7.69) | 22.82 |
Other Forecasting Options for SIMCERE PHARMAC
For every potential investor in SIMCERE, whether a beginner or expert, SIMCERE PHARMAC's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. SIMCERE Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in SIMCERE. Basic forecasting techniques help filter out the noise by identifying SIMCERE PHARMAC's price trends.SIMCERE PHARMAC Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with SIMCERE PHARMAC stock to make a market-neutral strategy. Peer analysis of SIMCERE PHARMAC could also be used in its relative valuation, which is a method of valuing SIMCERE PHARMAC by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
SIMCERE PHARMAC Market Strength Events
Market strength indicators help investors to evaluate how SIMCERE PHARMAC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading SIMCERE PHARMAC shares will generate the highest return on investment. By undertsting and applying SIMCERE PHARMAC stock market strength indicators, traders can identify SIMCERE PHARMAC GRP entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 1.31 | |||
| Day Typical Price | 1.31 | |||
| Price Action Indicator | 0.005 | |||
| Period Momentum Indicator | 0.01 | |||
| Relative Strength Index | 48.93 |
SIMCERE PHARMAC Risk Indicators
The analysis of SIMCERE PHARMAC's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in SIMCERE PHARMAC's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting simcere stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.15 | |||
| Standard Deviation | 2.81 | |||
| Variance | 7.87 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for SIMCERE PHARMAC
The number of cover stories for SIMCERE PHARMAC depends on current market conditions and SIMCERE PHARMAC's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that SIMCERE PHARMAC is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about SIMCERE PHARMAC's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in SIMCERE Stock
SIMCERE PHARMAC financial ratios help investors to determine whether SIMCERE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SIMCERE with respect to the benefits of owning SIMCERE PHARMAC security.